Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Stopping Cholesterol Drugs May Be… >
Stopping Cholesterol Drugs May Be Associated with Increased Risk of Parkinson's

Published: July 24, 2013.
By American Academy of Neurology
http://www.aan.com/go/pressroom

MINNEAPOLIS – People who stop taking cholesterol drugs may be at an increased risk for developing Parkinson's disease, according to research that appears in the July 24, 2013, online issue of Neurology¬ the medical journal of the American Academy of Neurology. Previous studies on the relationship between cholesterol drugs called statins and the risk of Parkinson's disease have had inconsistent results.

The current study involved 43,810 people in Taiwan who were taking statins and did not have Parkinson's disease. Taiwan's compulsory national health insurance program reimbursement policy requests that doctors stop prescribing statins once the patient's cholesterol reaches the treatment goal, which is contrary to standard treatment in the United States.

"This policy allowed us to see whether there was any difference in the risk of Parkinson's in people who stopped taking statins compared to the ones who kept taking them," said study author Jou-Wei Lin, MD, PhD, of National Taiwan University in Taipei.

The study found a difference between two types of statins. The use of lipophilic, or fat-soluble, statins such as simvastatin and atorvastatin was associated with a reduced risk of Parkinson's, while no such association was found for hydrophilic, or water-soluble, statins such as pravastatin and rosuvastatin.

Those who stopped taking the fat-soluble statins were 58 percent more likely to develop Parkinson's disease than those who kept taking the drugs, an absolute risk of 2.65 cases per one million person-days. This result was consistent even after adjusting for other conditions such as diabetes and high blood pressure.

The study also looked at how many people taking the two types of statins developed Parkinson's disease, compared to the number of person-days spent on the medication to come up with an incidence rate. A total of 25 people taking fat-soluble statins developed Parkinson's from a total of nearly 15 million person-days on the drugs, for a rate of 1.68 cases per one million person-days on the drugs. For the water-soluble statins, 14 people developed Parkinson's from nearly four million person-days on the drugs, for a rate of 3.52 cases per one million person-days on the drugs.

"The fat-soluble statins are better able to cross the blood-brain barrier than the water-soluble statins," Lin said.


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Parkinson 
1/10/13 
Saliva Gland Test for Parkinson's Shows Promise, Study Finds
By Mayo Clinic
PHOENIX — Described as a "big step forward" for research and treatment of Parkinson's disease, new research from Mayo Clinic in Arizona and Banner Sun Health Research Institute suggests …
Parkinson 
3/10/10 
Years of Smoking Associated with Lower Parkinson's Risk, Not Number of Cigarettes Per Day
By American Academy of Neurology
ST. PAUL, Minn. – Researchers have new insight into the relationship between Parkinson's disease and smoking. Several studies have shown that smokers have a lower risk of developing Parkinson's …
Disease 
6/23/10 
Tests Help Predict Falls in Parkinson's Disease
By American Academy of Neurology
ST. PAUL, Minn. –A group of tests may help predict which people with Parkinson's disease are more likely to fall, according to a study published in the June 23, …
Disease 
11/22/13 
UCLA, Emory Researchers Find a Chemical Signature for 'Fast' Form of Parkinson's
By University of California - Los Angeles
The physical decline experienced by Parkinson's disease patients eventually leads to disability and a lower quality of life. Depending on the individual, the disorder can progress rapidly or slowly. …
Patients 
4/11/12 
Meds Ease Depression in Parkinson's Patients Without Worsening Other Symptoms
By University of Rochester Medical Center
Today's anti-depressant medications can ease depression in Parkinson's patients without worsening other symptoms of the disease, according to a study published online in Neurology¬ the medical journal of the …
Symptoms 
1/15/13 
Parkinson's Can Lead to Anxiety And Other Non-motor Symptoms, Even Early On
By American Academy of Neurology
MINNEAPOLIS – While movement problems are the main symptom of Parkinson's disease, a new study shows that even early in the course of disease people frequently experience many non-motor …
Disease 
8/1/12 
Caffeine May Ease Parkinson's Symptoms
By McGill University Health Centre
Montreal, August 1, 2012 – Caffeine, which is widely consumed around the world in coffee, tea and soft drinks, may help control movement in people suffering from Parkinson's. This …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition
All contents are copyright of their owners except U.S. Government works. U.S. Government works are assumed to be in the public domain unless otherwise noted. Everything else copyright ScienceNewsline.